← Leaderboards
Tamer M A Mohamed
Baylor College Of Medicine
$5,113,243
Attributed
$5,893,440
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2020–25$2.5M$1.9M$1.3M$625K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,893,440 · 3
By mechanism
R01$5,333,440 · 2
R61$560,000 · 1
Top collaborators
- Todd K Rosengart1 shared
- Jonathan Satin1 shared
- Lior Zangi1 shared
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Juan Botas$8,658,926
- Barry Matthew Markaverich$5,206,019
- Liang Xie$3,447,032
- James Francis Martin$25,967,418
- Timothy A Benke$7,331,995
Others in their field
Other Emerging Leaders on “Cyclin B1”
- Magdalena Bieniasz · Oklahoma Medical Research Foundation$445,369
- Nicholas Gene Brown · Univ Of North Carolina Chapel Hill$384,735
- Lior Zangi · Icahn School Of Medicine At Mount Sinai$250,099
- Riham Raafat Elgharib Abouleisa · University Of Louisville$242,772
- Akshitkumar Mistry · Vanderbilt University Medical Center$19,645
Research focus
Cyclin B1Cardiac MyocytesOverexpressionHealingAdultCell CycleMyocardial InfarctionNatural RegenerationCdk4 GeneRattusCyclin D1Cdc2 GeneHeart FailureHeartIn VivoMuscle CellsIschemiaGene TherapyCell DivisionHeart FunctionKidneyBloodEfficacy TestingClinical Application
Grant awards (9)
Induction of Cardiomyocyte Proliferation via Transient Expression of Cell Cycle Factors as a Promising Therapy for Heart Failure$750,296
R01 · FY2025 · HL · contact PI
Defining the major signaling mechanism which controls spontaneous cardiomyocyte proliferation in the Neonatal Stage$746,800
R01 · FY2025 · HL · contact PI
Triple Gene Therapy for Ischemic Heart Failure$560,000
R61 · FY2025 · HL · contact PI
Induction of Cardiomyocyte Proliferation via Transient Expression of Cell Cycle Factors as a Promising Therapy for Heart Failure$761,149
R01 · FY2024 · HL · contact PI
Induction of Cardiomyocyte Proliferation via Transient Expression of Cell Cycle Factors as a Promising Therapy for Heart Failure$648,772
R01 · FY2023 · HL · contact PI
Induction of Cardiomyocyte Proliferation via Transient Expression of Cell Cycle Factors as a Promising Therapy for Heart Failure$121,403
R01 · FY2023 · HL · contact PI
Induction of Cardiomyocyte Proliferation via Transient Expression of Cell Cycle Factors as a Promising Therapy for Heart Failure$769,564
R01 · FY2022 · HL · contact PI
Induction of Cardiomyocyte Proliferation via Transient Expression of Cell Cycle Factors as a Promising Therapy for Heart Failure$767,728
R01 · FY2021 · HL · contact PI
Induction of Cardiomyocyte Proliferation via Transient Expression of Cell Cycle Factors as a Promising Therapy for Heart Failure$767,728
R01 · FY2020 · HL · contact PI